Market Overview

Benzinga's Top Upgrades, Downgrades For July 1, 2020

Share:

Upgrades

  • SunTrust Robinson Humphrey upgraded the stock for Cogent Communications Holdings Inc (NASDAQ: CCOI) from Hold to Buy. In the first quarter, Cogent Comms Hldgs showed an EPS of $0.20, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $92.96 and a 52-week-low of $53.24. Cogent Comms Hldgs's stock last closed at $77.36 per share.
  • B of A Securities changed the rating for Charles River Laboratories International Inc (NYSE: CRL) from Neutral to Buy. Charles River earned $1.84 in the first quarter, compared to $1.40 in the year-ago quarter. The stock has a 52-week-high of $189.85 and a 52-week-low of $95.58. Charles River's stock last closed at $174.22 per share.
  • Rosenblatt upgraded the stock for Square Inc (NYSE: SQ) from Neutral to Buy. In the first quarter, Square showed an EPS of ($0.02), compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $107.84 and a 52-week-low of $32.33. Square's stock last closed at $104.85 per share.
  • Deutsche Bank upgraded the stock for Caterpillar Inc (NYSE: CAT) from Hold to Buy. In the first quarter, Caterpillar showed an EPS of $1.60, compared to $2.94 from the year-ago quarter. The stock has a 52-week-high of $150.55 and a 52-week-low of $87.50. Caterpillar's stock last closed at $126.44 per share.
  • Bernstein upgraded the stock for Comcast Corp (NASDAQ: CMCSA) from Market Perform to Outperform. In the first quarter, Comcast showed an EPS of $0.71, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $47.74 and a 52-week-low of $31.70. Comcast's stock last closed at $38.98 per share.
  • Goldman Sachs changed the rating for Global Blood Therapeutics Inc (NASDAQ: GBT) from Neutral to Buy. For the first quarter, Global Blood Therapeutics had an EPS of ($1.20), compared to year-ago quarter EPS of ($0.87). The stock has a 52-week-high of $87.54 and a 52-week-low of $39.95. Global Blood Therapeutics's stock last closed at $63.13 per share.
  • For SailPoint Technologies Holdings Inc (NYSE: SAIL), Goldman Sachs upgraded the stock from Sell to Buy. SailPoint Technologies earned $0.04 in the first quarter, compared to $0.00 in the year-ago quarter. The stock has a 52-week-high of $28.00 and a 52-week-low of $11.61. SailPoint Technologies's stock last closed at $26.51 per share.
  • For Spire Inc (NYSE: SR), JP Morgan upgraded the stock from Underweight to Neutral. In the second quarter, Spire showed an EPS of $2.75, compared to $2.90 from the year-ago quarter. The stock has a 52-week-high of $88.00 and a 52-week-low of $57.37. Spire's stock last closed at $65.80 per share.
  • JP Morgan upgraded the stock for FedEx Corp (NYSE: FDX) from Neutral to Overweight. FedEx earned $2.53 in the fourth quarter, compared to $5.01 in the year-ago quarter. The stock has a 52-week-high of $178.50 and a 52-week-low of $88.69. FedEx's stock last closed at $140.10 per share.

 

Downgrades

  • For Texas Roadhouse Inc (NASDAQ: TXRH), Gordon Haskett downgraded the stock from Buy to Hold. Texas Roadhouse earned $0.24 in the first quarter, compared to $0.70 in the year-ago quarter. The stock has a 52-week-high of $72.49 and a 52-week-low of $25.15. Texas Roadhouse's stock last closed at $52.57 per share.
  • Janney Capital changed the rating for Rent-A-Center Inc (NASDAQ: RCII) from Buy to Neutral. For the first quarter, Rent-A-Center had an EPS of $0.67, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $31.14 and a 52-week-low of $11.69. Rent-A-Center's stock last closed at $27.82 per share.
  • Benchmark downgraded the stock for Invitae Corp (NYSE: NVTA) from Buy to Hold. For the first quarter, Invitae had an EPS of ($0.80), compared to year-ago quarter EPS of ($0.47). The stock has a 52-week-high of $30.49 and a 52-week-low of $7.42. Invitae's stock last closed at $30.32 per share.
  • Gordon Haskett downgraded the stock for Darden Restaurants Inc (NYSE: DRI) from Buy to Hold. Darden Restaurants earned ($1.24) in the fourth quarter, compared to $1.76 in the year-ago quarter. The stock has a 52-week-high of $128.41 and a 52-week-low of $26.15. Darden Restaurants's stock last closed at $75.75 per share.
  • Gordon Haskett changed the rating for Bloomin Brands Inc (NASDAQ: BLMN) from Buy to Hold. Bloomin Brands earned $0.14 in the first quarter, compared to $0.75 in the year-ago quarter. The stock has a 52-week-high of $24.29 and a 52-week-low of $4.54. Bloomin Brands's stock last closed at $10.66 per share.
  • Needham downgraded the stock for Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) from Buy to Hold. Zynerba Pharmaceuticals earned ($0.53) in the first quarter, compared to ($0.47) in the year-ago quarter. The stock has a 52-week-high of $15.70 and a 52-week-low of $2.55. Zynerba Pharmaceuticals's stock last closed at $3.37 per share.
  • HC Wainwright & Co. changed the rating for Replimune Group Inc (NASDAQ: REPL) from Buy to Neutral. In the fourth quarter, Replimune Group showed an EPS of ($0.41), compared to ($0.15) from the year-ago quarter. The stock has a 52-week-high of $26.22 and a 52-week-low of $8.58. Replimune Group's stock last closed at $24.85 per share.
  • For AGCO Corp (NYSE: AGCO), Deutsche Bank downgraded the stock from Buy to Hold. For the first quarter, AGCO had an EPS of $0.86, compared to year-ago quarter EPS of $0.86. The stock has a 52-week-high of $81.39 and a 52-week-low of $35.33. AGCO's stock last closed at $55.48 per share.
  • For GSX Techedu Inc (NYSE: GSX), Goldman Sachs downgraded the stock from Buy to Neutral. Interestingly, in the first quarter, GSX Techedu's EPS was $0.76. The stock has a 52-week-high of $62.75 and a 52-week-low of $8.83. GSX Techedu's stock last closed at $59.99 per share.
  • JP Morgan changed the rating for South Jersey Industries Inc (NYSE: SJI) from Neutral to Underweight. For the first quarter, South Jersey Indus had an EPS of $1.15, compared to year-ago quarter EPS of $1.09. The stock has a 52-week-high of $34.48 and a 52-week-low of $19.62. South Jersey Indus's stock last closed at $25.00 per share.

 

Initiations

  • For Marinus Pharmaceuticals Inc (NASDAQ: MRNS), Cowen & Co. initiated coverage, by setting the current rating at Outperform. Marinus Pharmaceuticals earned ($0.32) in the first quarter, compared to ($0.24) in the year-ago quarter. The stock has a 52-week-high of $4.83 and a 52-week-low of $0.77. Marinus Pharmaceuticals's stock last closed at $2.54 per share.
  • Benchmark initiated coverage on Halozyme Therapeutics Inc (NASDAQ: HALO) with a Buy rating. The price target for Halozyme Therapeutics is set at $39.00. Halozyme Therapeutics earned ($0.04) in the first quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $27.22 and a 52-week-low of $12.71. Halozyme Therapeutics's stock last closed at $26.81 per share.
  • KeyBanc initiated coverage on Coupa Software Inc (NASDAQ: COUP) with an Overweight rating. In the first quarter, Coupa Software showed an EPS of $0.20, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $280.15 and a 52-week-low of $99.01. Coupa Software's stock last closed at $277.04 per share.
  • With a rating of Overweight, Stephens & Co. initiated coverage on DraftKings Inc (NASDAQ: DKNG). The price target is set at $52.00 for DraftKings. DraftKings earned ($0.16) in the first quarter. The stock has a 52-week-high of $44.79 and a 52-week-low of $18.00. DraftKings's stock last closed at $33.26 per share.
  • With a rating of Outperform, Wedbush initiated coverage on Papa John's International Inc (NASDAQ: PZZA). The price target is set at $95.00 for Papa John's International. Papa John's International earned $0.15 in the first quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $85.00 and a 52-week-low of $28.55. Papa John's International's stock last closed at $79.41 per share.
  • JP Morgan initiated coverage on Varonis Systems Inc (NASDAQ: VRNS) with an Overweight rating. The price target for Varonis Systems is set at $130.00. Varonis Systems earned ($0.56) in the first quarter, compared to ($0.38) in the year-ago quarter. The stock has a 52-week-high of $93.33 and a 52-week-low of $48.95. Varonis Systems's stock last closed at $88.48 per share.
  • Stifel initiated coverage on WillScot Corp (NASDAQ: WSC) with a Buy rating. The price target for WillScot is set at $19.00. For the first quarter, WillScot had an EPS of ($0.03), compared to year-ago quarter EPS of ($0.09). The stock has a 52-week-high of $19.79 and a 52-week-low of $7.45. WillScot's stock last closed at $12.29 per share.
  • JP Morgan initiated coverage on Legend Biotech Corp (NASDAQ: LEGN) with an Overweight rating. The price target for Legend Biotech is set at $50.00. The stock has a 52-week-high of $42.88 and a 52-week-low of $35.00. Legend Biotech's stock last closed at $42.56 per share.
  • With a rating of Outperform, SVB Leerink initiated coverage on UnitedHealth Group Inc (NYSE: UNH). The price target is set at $360.00 for UnitedHealth Group. In the first quarter, UnitedHealth Group showed an EPS of $3.72, compared to $3.73 from the year-ago quarter. The stock has a 52-week-high of $315.84 and a 52-week-low of $187.72. UnitedHealth Group's stock last closed at $294.79 per share.
  • With a rating of Outperform, SVB Leerink initiated coverage on Humana Inc (NYSE: HUM). The price target is set at $465.00 for Humana. Humana earned $5.40 in the first quarter, compared to $4.48 in the year-ago quarter. The stock has a 52-week-high of $412.70 and a 52-week-low of $208.25. Humana's stock last closed at $388.21 per share.
  • With a rating of Market Perform, SVB Leerink initiated coverage on CVS Health Corp (NYSE: CVS). The price target is set at $72.00 for CVS Health. CVS Health earned $1.91 in the first quarter, compared to $1.62 in the year-ago quarter. The stock has a 52-week-high of $77.03 and a 52-week-low of $52.04. CVS Health's stock last closed at $64.95 per share.
  • With a rating of Outperform, SVB Leerink initiated coverage on Centene Corp (NYSE: CNC). The price target is set at $78.00 for Centene. Centene earned $0.86 in the first quarter, compared to $1.39 in the year-ago quarter. The stock has a 52-week-high of $74.70 and a 52-week-low of $41.62. Centene's stock last closed at $63.48 per share.
  • With a rating of Market Perform, SVB Leerink initiated coverage on Cigna Corp (NYSE: CI). The price target is set at $220.00 for Cigna. In the first quarter, Cigna showed an EPS of $4.69, compared to $3.90 from the year-ago quarter. The stock has a 52-week-high of $224.64 and a 52-week-low of $118.50. Cigna's stock last closed at $187.71 per share.
  • SVB Leerink initiated coverage on Anthem Inc (NYSE: ANTM) with an Outperform rating. The price target for Anthem is set at $325.00. In the first quarter, Anthem showed an EPS of $6.48, compared to $6.03 from the year-ago quarter. The stock has a 52-week-high of $312.48 and a 52-week-low of $171.03. Anthem's stock last closed at $262.99 per share.
 

Related Articles (AGCO + ANTM)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
ZTSGabelli & Co.Downgrades
AUPHHC Wainwright & Co.Maintains34.0
RCLCredit SuisseMaintains75.0
PINCCredit SuisseMaintains35.0
SUNCredit SuisseMaintains29.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com